Genmab A/S (Nasdaq: GMAB) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting conditional marketing authorization for epcoritamab (TEPKINLY®). This T-cell engaging bispecific antibody is intended as a monotherapy for…
Pulse Biosciences, Inc. (Nasdaq: PLSE), leveraging its CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, disclosed today the preliminary outcomes of its recently concluded rights offering. The offering, which expired at 5:00 p.m. Eastern Time on June 26, 2024, set the…
Tebra, the comprehensive platform for independent healthcare providers, has announced multiple new product enhancements in the second quarter aimed at maximizing time spent with patients. This announcement coincides with the release of a recent survey revealing that 85% of independent…
Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) has unanimously recommended CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine)…
ObjectiveHealth, a Nashville-based integrated research and technology platform company, has announced an expansion of its partnership with QualDerm Partners, LLC, a leading dermatology and skin care management services organization also based in Nashville. This collaboration aims to integrate clinical research…
Genoks, a leading genomics healthcare company based in Turkey, has partnered with Velsera, a global healthcare technology firm specializing in a universal software platform connecting clinical care with discovery. Together, they aim to advance cancer diagnostics and treatment not only…
Last year, Brenus Pharma was chosen to join CDL Cancer, a global mentoring program supporting highly scalable, science-driven companies advancing cancer treatments. Distinguished by its innovative STC platform focused on developing next-generation therapeutic cancer vaccines, Brenus impressed during a rigorous…
Augustine Therapeutics, a pioneering biotech firm dedicated to innovative therapies for neurodegenerative and cardiometabolic diseases, has successfully secured EUR 17 million (USD 18.5 million) in the initial closing of its Series A funding round. The financing was led by Asabys…
“This award is a testament to our team’s dedication and innovation in developing the FertilityNow app, which offers personalized, convenient, and effective support to make fertility care more accessible and efficient,” said David Adamson, MD, founder and CEO of ARC…
PQE Group, a leading consultancy in the Life Science sector, has launched its new Regulated Artificial Intelligence & Data Analytics division, marking a significant advancement since the introduction of AI-based tools in industrial settings. With over 2000 employees, the Italian…
Swift Medical, a leading digital health technology company specializing in enhancing clinical outcomes in chronic and acute wound care, is pleased to announce the appointment of Dwayne Sansone as Chief Executive Officer and Stratos Davlos as Chief Technology Officer. These…
Greenspace Health and Behavioral Health Innovations (BHI) have announced a strategic partnership aimed at enhancing access to BHI’s evidence-based assessments through digital platforms. This collaboration seeks to streamline the administration of assessments such as the UCLA PTSD Reaction Index, crucial…